We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$611M
1-Year Est. Return
61.48%
This Fund
S&P 500
This Quarter
Est. Return
+3.92%
1 Year Est. Return
+61.48%
3 Year Est. Return
+199.5%
5 Year Est. Return
+275.62%
10 Year Est. Return
+998.75%
AUM
$684M
AUM Growth
-$28.6M
(-4%)
Cap. Flow
-$43.8M
Cap. Flow
% of AUM
-6.4%
Top 10 Holdings %
Top 10 Hldgs %
12.14%
Holding
440
New
109
Increased
100
Reduced
127
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LM
Legg Mason, Inc.
LM
|
+$5.96M |
| 2 |
Evercore
EVR
|
+$4.79M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.29M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$4.22M |
| 5 |
Avista
AVA
|
+$4.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$5.21M |
| 2 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$5.17M |
| 3 |
Southwest Gas
SWX
|
+$5.09M |
| 4 |
Sunstone Hotel Investors
SHO
|
+$4.25M |
| 5 |
HRG
HRG Group, Inc.
HRG
|
+$3.83M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.55% |
| 2 | Technology | 13.89% |
| 3 | Industrials | 13.5% |
| 4 | Healthcare | 12.43% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$930B
| $12.9M | 1.89% |
141,078
+20,446
| +17% | +$1.76M |
|
2
Boeing
BA
$165B
| $11.1M | 1.62% |
55,969
+942
| +2% | +$175K |
|
3
Pfizer
PFE
$143B
| $8.91M | 1.3% |
279,496
+7,127
| +3% | +$225K |
|
4
AT&T
T
$157B
| $8.85M | 1.29% |
310,563
-80,111
| -21% | -$2.36M |
|
5
Citigroup
C
$221B
| $7.58M | 1.11% |
113,317
-5,492
| -5% | -$337K |
|
6
AbbVie
ABBV
$454B
| $7.27M | 1.06% |
100,295
-16,690
| -14% | -$1.12M |
|
7
Bank of America
BAC
$430B
| $6.86M | 1% |
282,882
-18,522
| -6% | -$432K |
|
8
Walmart Inc
WMT
$863B
| $6.76M | 0.99% |
267,834
-20,655
| -7% | -$524K |
|
9
Microsoft
MSFT
$2.83T
| $6.59M | 0.96% |
95,669
+38,706
| +68% | +$2.66M |
|
10
Apple
AAPL
$4.72T
| $6.18M | 0.9% |
171,668
-76,288
| -31% | -$2.82M |
|
11
Valero Energy
VLO
$90.6B
| $6.01M | 0.88% |
89,113
-847
| -0.9% | -$54.9K |
|
|
LM
12
DELISTED
Legg Mason, Inc.
LM
| $6M | 0.88% |
+157,340
| New | +$5.96M |
|
13
Amgen
AMGN
$201B
| $5.79M | 0.85% |
33,587
-1,230
| -4% | -$200K |
|
14
Teradata
TDC
$2.6B
| $5.12M | 0.75% |
173,470
+2,339
| +1% | +$68.5K |
|
|
TVPT
15
DELISTED
Travelport Worldwide Limited
TVPT
| $5.01M | 0.73% |
363,993
+87,417
| +32% | +$1.16M |
|
|
16
Evercore
EVR
$13B
| $4.64M | 0.68% |
+65,834
| New | +$4.79M |
|
|
SAFM
17
DELISTED
Sanderson Farms Inc
SAFM
| $4.6M | 0.67% |
39,748
+6,172
| +18% | +$717K |
|
|
DF
18
DELISTED
Dean Foods Company
DF
| $4.6M | 0.67% |
270,435
+14,227
| +6% | +$267K |
|
19
Saic
SAIC
$4.93B
| $4.57M | 0.67% |
65,838
+32,227
| +96% | +$2.37M |
|
|
LHO
20
DELISTED
LaSalle Hotel Properties
LHO
| $4.5M | 0.66% |
151,106
-13,027
| -8% | -$382K |
|
21
Capital One
COF
$123B
| $4.48M | 0.66% |
54,209
-5,167
| -9% | -$420K |
|
|
ANDV
22
DELISTED
Andeavor
ANDV
| $4.44M | 0.65% |
47,406
+11,178
| +31% | +$943K |
|
|
23
Bristol-Myers Squibb
BMY
$126B
| $4.39M | 0.64% |
+78,795
| New | +$4.29M |
|
24
MGIC Investment
MTG
$6.12B
| $4.29M | 0.63% |
383,314
-4,036
| -1% | -$43.4K |
|
25
Altria Group
MO
$120B
| $4.27M | 0.62% |
57,341
+5,854
| +11% | +$428K |
|
Similar funds
FFWA
VV
CBB
1SAMC
PM
PL
BFC
DCM
Convergence Investment Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Convergence Investment Partners held 440 positions worth $684M, down 4% from $712M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Convergence Investment Partners withdrew a net $43.8M in Q2 2017, closing 102 positions and reducing 127 holdings. Its most notable exit was Darling Ingredients, an estimated $5.21M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Convergence Investment Partners opened a new position in Legg Mason, Inc. worth $6M.
- Convergence Investment Partners's largest Q2 2017 buy was Legg Mason, Inc.: 157,340 shares worth $6M.
- Convergence Investment Partners added most to Sabra Healthcare REIT in Q2 2017, an estimated $2.78M increase.
- Convergence Investment Partners's biggest Q2 2017 reduction was Sunstone Hotel Investors, cutting an estimated $4.25M.
- Convergence Investment Partners fully exited Darling Ingredients in Q2 2017, selling an estimated $5.21M.
- Convergence Investment Partners's ten largest holdings make up 12% of its $684M portfolio in Q2 2017.
- Convergence Investment Partners opened 109 new positions and closed 102 in Q2 2017.
- Convergence Investment Partners's portfolio value fell 4% quarter-over-quarter to $684M.
Based on Convergence Investment Partners's 13F filing for Q2 2017, filed 2 Aug 2017.